Blog

Phenobarbital has a longer half-life than benzodiazepines and has the pharmacodynamic advantage of acting on both GABA and glutamate (24). Studies have assessed use of barbiturates in the treatment of alcohol withdrawal syndrome. There has been a general concern that phenobarbital may have an increased risk of sedation prompting invasive mechanical ventilation (49). A metaanalysis compared phenobarbital versus benzodiazepines for alcohol withdrawal syndrome in the emergency department and/or intensive care unit (49). Twelve studies were included (1934 subjects) concluding that phenobarbital did not increase the risk of intubation, and the frequency of seizures was similar between both groups. A systematic review of clinical trials considered seven studies using barbiturates versus benzodiazepines for the treatment of acute withdrawal syndrome (44).

Healthcare

• F10.231 is a billable diagnosis code used to specify a medical diagnosis of alcohol dependence with withdrawal delirium.
• The heavy drinking that often occurs in alcohol use disorder, and can also occur in short-term episodes called binge drinking, can lead to a life-threatening overdose known as alcohol poisoning.
• Similar to benzodiazepines, dose regimens vary from study to study with phenobarbital (44).
• The combination of benzodiazepines with phenobarbital (single intravenous dose of 10 mg/kg) may also prevent ICU admission and ventilation, with a similar safety profile in comparison to benzodiazepines alone (56).

This ICD-10-CM code is used for a patient confirmed to have alcohol abuse who is experiencing withdrawal with delirium. Withdrawal delirium, also called delirium tremens, is considered the most severe complication of alcohol withdrawal and is characterized by hallucinations, disorientation, anxiety, and tremors. Case-control studies convincingly demonstrate the association of first seizures to alcohol use in a dose-dependent manner. For example, the risk was 3-fold for people drinking 51 to 100 g alcohol/day and steadily increased to 8-fold and more than 16-fold for people drinking 101 to 200 g/day and more than Alcohol Withdrawal 200 g/day (47; 36).

Alcohol-related disorders

When assessing for alcohol withdrawal, therapists must pay attention to when symptoms start in relation to the client’s last drink. As mentioned above, withdrawal symptoms typically begin within 6-24 hours after the last drink, peak in intensity around hours, and gradually subside over the following days to weeks. F10.239 belongs to the broader category of alcohol-related disorders in the ICD-10 classification system.

• Even when diagnosis codes differ, similar conditions can be grouped together based on their clinical relevance.
• Managing alcohol withdrawal seizures requires a multi-faceted approach focused on preventing further seizures, alleviating withdrawal symptoms, and supporting overall patient stability.
• During this stage, continuous monitoring and medical intervention are crucial to prevent complications.
• Epilepsy is a brain disorder that causes people to have recurring seizures.
• The presence of both status epilepticus and focal seizures should prompt a careful evaluation for structural brain lesions and underlying epilepsy (07).

How Does F10.239 Help in Long-Term Care?

• These symptoms can persist for weeks or even months and require ongoing management.
• Not everyone who binge drinks has an AUD, but they are at higher risk for getting one.
• Alcohol withdrawal is a significant and potentially life-threatening condition that occurs when an individual who has been consuming alcohol heavily for a prolonged period suddenly stops or drastically reduces their intake.
• Providers Care Billing LLC is a leading medical billing services company, specializing in comprehensive revenue cycle management for healthcare providers across the USA.
• This page provides healthcare professionals with information on diagnosing and managing AWS, including related ICD-10 codes and best practices for patient care.

When such symptoms come without a seizure, hallucination, or confusion, it is perfect to employ F10.239 as an accurate code. But when the patient’s symptoms are more severe, a different code is selected. This code is used to classify cases where alcohol use is present but not further specified as abuse, dependence, or another specific alcohol-related disorder.

Seizure risk and delirium were not assessed as outcomes, and the reviewers concluded that there was insufficient and very low-quality evidence to draw any conclusions (38). In addition, alpha 2-adrenergic agonists (clonidine), beta-blockers, or dexmedetomidine should not be used in the prevention or treatment of alcohol-withdrawal seizures (79). Because alcohol withdrawal seizures are a symptom of severe acute withdrawal syndrome, they should be treated as such.

What are the treatments for delirium?

A metaanalysis of 30 randomized controlled trials compared benzodiazepines versus non-benzodiazepines treatment for alcohol withdrawal syndrome (15). Results from this analysis on tapering methods favored antiseizure medications (gabapentin and carbamazepine) over benzodiazepines (chlordiazepoxide, lorazepam, and oxazepam) for reducing CIWA-Ar scale scores. The patient should be checked for other signs of alcohol withdrawal such as tachycardia, tachypnea, mydriasis, elevated blood pressure, hyperthermia, diaphoresis, and tremor, among others (27). In addition, perform a neurologic examination to determine possible etiology (79).